NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $2.22 | Prev. Close $2.25 | Circuit Range N/A |
Day Range $2.19 - $2.24 | Year Range $1.64 - $3.83 | Volume 6,214 |
Average Traded $2.21 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $2.33 | $2.27 | +1.80% |
07-Apr-26 | $2.23 | $2.23 | -1.33% |
06-Apr-26 | $2.21 | $2.25 | +2.27% |
02-Apr-26 | $2.13 | $2.21 | +2.08% |
01-Apr-26 | $2.20 | $2.16 | +1.17% |
31-Mar-26 | $2.10 | $2.13 | +1.91% |
30-Mar-26 | $2.13 | $2.10 | -4.34% |